Strength
90 mg/1
Manufacturer
AvPAKNDC
50268059915
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077410On Market Since
2/11/2011
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE ER 90 MG TABLET has been published 464 times since Nov 15, 2017, and over the history we have for it it has declined 36.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2692 per EA |
|---|---|
| All-time high | $0.6084 (Nov 13, 2019) |
| All-time low | $0.1871 (Nov 20, 2024) |
| 52-week high | $0.2819 |
| 52-week low | $0.2279 |
| Median price | $0.3497 |
| Average price | $0.3622 |
| Largest weekly change | -29.3% (Apr 22, 2020) |
| Weeks tracked | 464 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AvPAK manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nifedipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE ER 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE ER 90 MG TABLET, manufactured by AvPAK, is $0.2692 per EA (NDC 50268059915), effective Sep 30, 2026.
How has the price of NIFEDIPINE ER 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE ER 90 MG TABLET has declined 36.4%. It has been tracked across 464 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE ER 90 MG TABLET?
Since Nov 15, 2017, the NADAC for NIFEDIPINE ER 90 MG TABLET has ranged from a low of $0.1871 (Nov 20, 2024) to a high of $0.6084 (Nov 13, 2019), with a median of $0.3497 per EA.
Are there cheaper alternatives to NIFEDIPINE ER 90 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIFEDIPINE ER 90 MG TABLET, is $0.2225 per EA — about 17% below NIFEDIPINE ER 90 MG TABLET.
Who manufactures NIFEDIPINE ER 90 MG TABLET?
NIFEDIPINE ER 90 MG TABLET (NDC 50268059915) is labeled by AvPAK, and CMS classifies it as a generic product.